文献速递胃肠外科围术期管理与 ERAS

结直肠癌贫血患者术前口服与静脉铁剂的随机临床试验

Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer.
PubMed 文献 · Br J Surg · 2017-01-16

这项随机临床试验纳入116例非转移性结直肠腺癌贫血患者,比较术前口服硫酸亚铁与静脉羧基麦芽糖铁对围术期输血需求的影响。结果显示两组输血量及输血人数无差异,但静脉铁剂在提升血红蛋白、改善贫血及铁缺乏指标方面优于口服铁剂。

要点

  • 静脉铁剂未减少结直肠癌贫血患者围术期输血需求
  • 静脉铁剂提升血红蛋白幅度显著高于口服铁剂
  • 静脉铁剂组术前贫血患者比例更低

核心结论

  • 静脉铁剂未降低输血需求,但在治疗结直肠癌手术患者术前贫血和铁缺乏方面比口服铁剂更有效。

研究设计与样本

  • 随机临床试验,招募至少术前2周的非转移性结直肠腺癌贫血患者,随机接受口服硫酸亚铁或静脉羧基麦芽糖铁,共116例纳入分析。

临床怎么用

  • 对于结直肠癌合并贫血患者,术前可考虑使用静脉铁剂以更有效纠正贫血和铁缺乏,但不应期望其减少围术期输血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of preoperative anaemia is recommended as part of patient blood management, aiming to minimize perioperative allogeneic red blood cell transfusion. No clear evidence exists outlining which treatment modality should be used in patients with colorectal cancer. The study aimed to compare the efficacy of preoperative intravenous and oral iron in reducing blood transfusion use in anaemic patients undergoing elective colorectal cancer surgery. METHODS: Anaemic patients with non-metastatic colorectal adenocarcinoma were recruited at least 2 weeks before surgery and randomized to receive oral (ferrous sulphate) or intravenous (ferric carboxymaltose) iron. Perioperative changes in haemoglobin, ferritin, transferrin saturation and blood transfusion use were recorded until postoperative outpatient review. RESULTS: Some 116 patients were included in the study. There was no difference in blood transfusion use from recruitment to trial completion in terms of either volume of blood administered (P = 0·841) or number of patients transfused (P = 0·470). Despite this, increases in haemoglobin after treatment were higher with intravenous iron (median 1·55 (i.q.r. 0·93-2·58) versus 0·50 (-0·13 to 1·33) g/dl; P < 0·001), which was associated with fewer anaemic patients at the time of surgery (75 versus 90 per cent; P = 0·048). Haemoglobin levels were thus higher at surgery after treatment with intravenous than with oral iron (mean 11·9 (95 per cent c.i. 11·5 to 12·3) versus 11·0 (10·6 to 11·4) g/dl respectively; P = 0·002), as were ferritin (P < 0·001) and transferrin saturation (P < 0·001) levels. CONCLUSION: Intravenous iron did not reduce the blood transfusion requirement but was more effective than oral iron at treating preoperative anaemia and iron deficiency in patients undergoing colorectal cancer surgery.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Keeler BD, Simpson JA, Ng O, et al. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer. Br J Surg. 2017. PMID: 28092401. doi:10.1002/bjs.10328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。